Molecular Psychiatry - Table of Contents alert Volume 21 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 21, Issue 4 (April 2016) In this issue Image News and Commentary Perspective Expert Review Immediate Communication Original Articles Erratum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Translational Psychiatry is an online-only, open access journal exploring the translational pathway between research in neuroscience and conceptually novel treatments. The journal has an Impact Factor of 5.62. Explore the benefits of submitting your next research article. Image Top Impulsivity is predicted by the thinness of the insular cortex in rats A Belin-Rauscent, M-L Daniel, M Puaud, B Jupp, S Sawiak, D Howett, C McKenzie, D Caprioli, M Besson, T W Robbins, B J Everitt, J W Dalley and D Belin Mol Psychiatry 2016 21: 445; 10.1038/mp.2016.32 Full Text | PDF News and Commentary Top Adult neurogenesis in the human striatum: possible implications for psychiatric disorders D Inta, U E Lang, S Borgwardt, A Meyer-Lindenberg and P Gass Mol Psychiatry 2016 21: 446-447; advance online publication, February 16, 2016; 10.1038/mp.2016.8 Full Text | PDF Perspective Top Understanding how non-coding genomic polymorphisms affect gene expression OPEN S E Koester and T R Insel Mol Psychiatry 2016 21: 448-449; advance online publication, January 26, 2016; 10.1038/mp.2015.226 Abstract | Full Text | PDF Expert Review Top Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders OPEN M A Lebow and A Chen Mol Psychiatry 2016 21: 450-463; advance online publication, February 16, 2016; 10.1038/mp.2016.1 Abstract | Full Text | PDF Immediate Communication Top Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications A Talati, K M Keyes and D S Hasin Mol Psychiatry 2016 21: 464-471; advance online publication, January 26, 2016; 10.1038/mp.2015.224 Abstract | Full Text | PDF Original Articles Top MAOA expression predicts vulnerability for alcohol use R Cervera-Juanes, L J Wilhem, B Park, R Lee, J Locke, C Helms, S Gonzales, G Wand, S R Jones, K A Grant and B Ferguson Mol Psychiatry 2016 21: 472-479; advance online publication, July 7, 2015; 10.1038/mp.2015.93 Abstract | Full Text | PDF GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper S Doly, H Shirvani, G Gäta, F J Meye, M-B Emerit, H Enslen, L Achour, L Pardo-Lopez, S-K Yang, V Armand, R Gardette, B Giros, M Gassmann, B Bettler, M Mameli, M Darmon and S Marullo Mol Psychiatry 2016 21: 480-490; advance online publication, June 2, 2015; 10.1038/mp.2015.72 Abstract | Full Text | PDF From impulses to maladaptive actions: the insula is a neurobiological gate for the development of compulsive behavior A Belin-Rauscent, M-L Daniel, M Puaud, B Jupp, S Sawiak, D Howett, C McKenzie, D Caprioli, M Besson, T W Robbins, B J Everitt, J W Dalley and D Belin Mol Psychiatry 2016 21: 491-499; advance online publication, September 15, 2015; 10.1038/mp.2015.140 Abstract | Full Text | PDF Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies M A Fullana, B J Harrison, C Soriano-Mas, B Vervliet, N Cardoner, A Àvila-Parcet and J Radua Mol Psychiatry 2016 21: 500-508; advance online publication, June 30, 2015; 10.1038/mp.2015.88 Abstract | Full Text | PDF Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides S G Torres-Platas, C Nagy, M Wakid, G Turecki and N Mechawar Mol Psychiatry 2016 21: 509-515; advance online publication, June 2, 2015; 10.1038/mp.2015.65 Abstract | Full Text | PDF Polygenic dissection of major depression clinical heterogeneity Y Milaneschi, F Lamers, W J Peyrot, A Abdellaoui, G Willemsen, J-J Hottenga, R Jansen, H Mbarek, A Dehghan, C Lu, CHARGE inflammation working group, D I Boomsma and B W J H Penninx Mol Psychiatry 2016 21: 516-522; advance online publication, June 30, 2015; 10.1038/mp.2015.86 Abstract | Full Text | PDF Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression OPEN F Hieronymus, J F Emilsson, S Nilsson and E Eriksson Mol Psychiatry 2016 21: 523-530; advance online publication, April 28, 2015; 10.1038/mp.2015.53 Abstract | Full Text | PDF Biophysical changes in subcortical nuclei: the impact of diabetes and major depression A Kumar, S Yang, O Ajilore, M Wu, J Cohen, M Lamar and D Bhaumik Mol Psychiatry 2016 21: 531-536; advance online publication, July 14, 2015; 10.1038/mp.2015.89 Abstract | Full Text | PDF Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa P B Shih, J Yang, C Morisseau, J B German, A A Scott-Van Zeeland, A M Armando, O Quehenberger, A W Bergen, P Magistretti, W Berrettini, K A Halmi, N Schork, B D Hammock and W Kaye Mol Psychiatry 2016 21: 537-546; advance online publication, March 31, 2015; 10.1038/mp.2015.26 Abstract | Full Text | PDF Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium OPEN T G M van Erp, D P Hibar, J M Rasmussen, D C Glahn, G D Pearlson, O A Andreassen, I Agartz, L T Westlye, U K Haukvik, A M Dale, I Melle, C B Hartberg, O Gruber, B Kraemer, D Zilles, G Donohoe, S Kelly, C McDonald, D W Morris, D M Cannon, A Corvin, M W J Machielsen, L Koenders, L de Haan, D J Veltman, T D Satterthwaite, D H Wolf, R C Gur, R E Gur, S G Potkin, D H Mathalon, B A Mueller, A Preda, F Macciardi, S Ehrlich, E Walton, J Hass, V D Calhoun, H J Bockholt, S R Sponheim, J M Shoemaker, N E M van Haren, H E H Pol, R A Ophoff, R S Kahn, R Roiz-Santiañez, B Crespo-Facorro, L Wang, K I Alpert, E G Jönsson, R Dimitrova, C Bois, H C Whalley, A M McIntosh, S M Lawrie, R Hashimoto, P M Thompson and J A Turner for the ENIGMA Schizophrenia Working Group Mol Psychiatry 2016 21: 547-553; advance online publication, June 2, 2015; 10.1038/mp.2015.63 Abstract | Full Text | PDF C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications B S Fernandes, J Steiner, H-G Bernstein, S Dodd, J A Pasco, O M Dean, P Nardin, C-A Gonçalves and M Berk Mol Psychiatry 2016 21: 554-564; advance online publication, July 14, 2015; 10.1038/mp.2015.87 Abstract | Full Text | PDF ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila OPEN M van der Voet, B Harich, B Franke and A Schenck Mol Psychiatry 2016 21: 565-573; advance online publication, May 12, 2015; 10.1038/mp.2015.55 Abstract | Full Text | PDF CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies OPEN L R Gray, D Cowley, C Welsh, H K Lu, B J Brew, S R Lewin, S L Wesselingh, P R Gorry and M J Churchill Mol Psychiatry 2016 21: 574-584; advance online publication, August 25, 2015; 10.1038/mp.2015.111 Abstract | Full Text | PDF Erratum Top Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium T G M van Erp, D P Hibar, J M Rasmussen, D C Glahn, G D Pearlson, O A Andreassen, I Agartz, L T Westlye, U K Haukvik, A M Dale, I Melle, C B Hartberg, O Gruber, B Kraemer, D Zilles, G Donohoe, S Kelly, C McDonald, D W Morris, D M Cannon, A Corvin, M W J Machielsen, L Koenders, L de Haan, D J Veltman, T D Satterthwaite, D H Wolf, R C Gur, R E Gur, S G Potkin, D H Mathalon, B A Mueller, A Preda, F Macciardi, S Ehrlich, E Walton, J Hass, V D Calhoun, H J Bockholt, S R Sponheim, J M Shoemaker, N E M van Haren, H E H Pol, R A Ophoff, R S Kahn, R Roiz-Santiañez, B Crespo-Facorro, L Wang, K I Alpert, E G Jönsson, R Dimitrova, C Bois, H C Whalley, A M McIntosh, S M Lawrie, R Hashimoto, P M Thompson and J A Turner for the ENIGMA Schizophrenia Working Group Mol Psychiatry 2016 21: 585; advance online publication, August 18, 2015; 10.1038/mp.2015.118 Full Text | PDF Advertisement Open for Submissions An interdisciplinary journal dedicated to publishing high-quality open research relevant to all aspects of schizophrenia and psychosis. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.